UK - The £400m Roche Products Pension Fund has lambasted consultants Hewitt Bacon & Woodrow (HB&W) and has decided to sever a 24 year relationship with the firm.
Secretary to the fund for the pharmaceuticals company Douglas Ross said that the decision to replace Hewitt Bacon & Woodrow - which formed part of a “good practice” review - was driven by dissatis...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here